{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-090765","form_type":"8-K","ticker":"EMMA","cik":"0000822370","company_name":"Emmaus Life Sciences, Inc.","filed_at":"2024-10-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:11.105192+00:00","generated_at":"2026-05-30T10:14:34.801192+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Emmaus Life Sciences engages Marcum LLP as new auditor for FY 2024","bullets":["Audit Committee appointed Marcum LLP as independent accountant on October 22, 2024.","Marcum will audit the quarter ended September 30, 2024 and year ending December 31, 2024.","Company did not consult Marcum on any matters described in Item 304(a)(2) of Reg S-K prior to engagement."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-090765","json":"https://secwatch.observer/filing/0001213900-24-090765.json","markdown":"https://secwatch.observer/filing/0001213900-24-090765.md","text":"https://secwatch.observer/filing/0001213900-24-090765.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/822370/000121390024090765/0001213900-24-090765-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/822370/000121390024090765/ea0218652-8k_emmaus.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T10:14:34.801192+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}